163 related articles for article (PubMed ID: 10080930)
41. CD44 plays a co-stimulatory role in murine T cell activation: ligation of CD44 selectively co-stimulates IL-2 production, but not proliferation in TCR-stimulated murine Th1 cells.
Sommer F; Huber M; Röllinghoff M; Lohoff M
Int Immunol; 1995 Nov; 7(11):1779-86. PubMed ID: 8580076
[TBL] [Abstract][Full Text] [Related]
42. Immune stimulatory and anti-tumor properties of anti-CD3 and BAT monoclonal antibodies: a comparative study.
Hardy B; Kovjazin R; Raiter A; Ganor N; Novogrodsky A
Hum Antibodies; 1997; 8(2):95-8. PubMed ID: 9289394
[TBL] [Abstract][Full Text] [Related]
43. Characterization of murine CD70 by molecular cloning and mAb.
Oshima H; Nakano H; Nohara C; Kobata T; Nakajima A; Jenkins NA; Gilbert DJ; Copeland NG; Muto T; Yagita H; Okumura K
Int Immunol; 1998 Apr; 10(4):517-26. PubMed ID: 9620608
[TBL] [Abstract][Full Text] [Related]
44. CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.
Blazar BR; Levy RB; Mak TW; Panoskaltsis-Mortari A; Muta H; Jones M; Roskos M; Serody JS; Yagita H; Podack ER; Taylor PA
J Immunol; 2004 Sep; 173(5):2933-41. PubMed ID: 15322151
[TBL] [Abstract][Full Text] [Related]
45. An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.
Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
Cancer Res; 1998 Mar; 58(6):1116-9. PubMed ID: 9515791
[TBL] [Abstract][Full Text] [Related]
46. CD30 molecule (Ki-1 Ag): more than just a marker of CD30+ lymphoma.
Pizzolo G; Romagnani S
Haematologica; 1995; 80(4):357-66. PubMed ID: 7590507
[No Abstract] [Full Text] [Related]
47. Characterization of the CD30L binding domain on the human CD30 molecule using anti-CD30 antibodies.
Franke AC; Jung D; Ellis TM
Hybridoma; 2000 Feb; 19(1):43-8. PubMed ID: 10768840
[TBL] [Abstract][Full Text] [Related]
48. Relative abilities of 4-1BB (CD137) and CD28 to co-stimulate the response of cytokine deflected Th1 and Th2 cells.
Vinay DS; Kwon BS
Immunobiology; 1999 Jun; 200(2):246-63. PubMed ID: 10416132
[TBL] [Abstract][Full Text] [Related]
49. [Blocking ICOS-B7h signal pathway by ICOS-Ig fusion protein inhibits function of allogeneic T lymphocytes].
Bao XC; Wang JM; Shen Q; Zhou H; Yang JM; Song NX; Wang B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):913-7. PubMed ID: 19698228
[TBL] [Abstract][Full Text] [Related]
50. Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30.
Hargreaves PG; Al-Shamkhani A
Eur J Immunol; 2002 Jan; 32(1):163-73. PubMed ID: 11754357
[TBL] [Abstract][Full Text] [Related]
51. Agonistic and antagonistic properties of CD40 mAb G28-5 are dependent on binding valency.
Ledbetter JA; Grosmaire LS; Hollenbaugh D; Aruffo A; Nadler SG
Circ Shock; 1994 Oct; 44(2):67-72. PubMed ID: 7743602
[TBL] [Abstract][Full Text] [Related]
52. CD30 in systemic mastocytosis.
van Anrooij B; Kluin PM; Oude Elberink JN; Kluin-Nelemans JC
Immunol Allergy Clin North Am; 2014 May; 34(2):341-55. PubMed ID: 24745678
[TBL] [Abstract][Full Text] [Related]
53. Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand.
Willers J; Dummer R; Kempf W; Kündig T; Burg G; Kadin ME
Clin Cancer Res; 2003 Jul; 9(7):2744-54. PubMed ID: 12855655
[TBL] [Abstract][Full Text] [Related]
54. Conformation changes of p53 proteins in regulation of murine T lymphocyte proliferation.
Wu J; Wang M; Li X; Sheng Y
Cell Mol Biol Res; 1993; 39(1):27-31. PubMed ID: 8287068
[TBL] [Abstract][Full Text] [Related]
55. Expression of prohibitins on the surface of activated T cells.
Yurugi H; Tanida S; Ishida A; Akita K; Toda M; Inoue M; Nakada H
Biochem Biophys Res Commun; 2012 Apr; 420(2):275-80. PubMed ID: 22417827
[TBL] [Abstract][Full Text] [Related]
56. CD30+ lymphocytes in chronic gingivitis from HIV-positive patients: a pilot study.
Gomez RS; de Souza PE; da Costa JE; Araújo NS
J Periodontol; 1997 Sep; 68(9):881-3. PubMed ID: 9379333
[TBL] [Abstract][Full Text] [Related]
57. CD30L up-regulates CD30 and IL-4 expression by T cells.
Rossi FM; Degan M; Mazzocut-Zecchin L; Di Francia R; Aldinucci D; Pinto A; Gattei V
FEBS Lett; 2001 Nov; 508(3):418-22. PubMed ID: 11728464
[TBL] [Abstract][Full Text] [Related]
58. Different regulatory effects of pentoxifylline on human T cell activation pathways.
Dong RP; Umezawa Y; Ikushima H; Munakata Y; Schlossman SF; Morimoto C
J Clin Immunol; 1997 May; 17(3):247-52. PubMed ID: 9168405
[TBL] [Abstract][Full Text] [Related]
59. Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN-gamma secretion of T cells and NK cell-mediated lysis of Hodgkin's lymphoma-derived tumor cells.
Heuser C; Diehl V; Abken H; Hombach A
Int J Cancer; 2003 Sep; 106(4):545-552. PubMed ID: 12845650
[TBL] [Abstract][Full Text] [Related]
60. Deciphering CD30 ligand biology and its role in humoral immunity.
Kennedy MK; Willis CR; Armitage RJ
Immunology; 2006 Jun; 118(2):143-52. PubMed ID: 16771849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
